Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ALECBearishCorporate Developmentsnews

High materiality9/10

Alector prices 36.6M share offering at $2.05, about $75 million proceeds

Oct 16, 2026, 7:45 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Dilutive equity offering expands share count and may pressure near-term EPS; market often discounts new stock issued at or near pricing. Historical examples show post-offering stock underperforming temporarily unless proceeds meaningfully improve execution or reduce burn rate.

AI summary

What happened, with direct paths to the underlying reporting

Alector priced an underwritten offering of 36.6 million common shares at $2.05, roughly $75 million gross proceeds, closing around Oct 19, 2026. The deal is dilutive and stock may be pressured despite premium to Oct 15 close; the cash could support pipeline work.

Alector prices 36.6M shares at $2.05. Offering price up 7.3% from prior close.
Gross proceeds ~$75.0M before expenses; closing around Oct 19, 2026.
All shares offered by Alector; dilution risk accompanies new equity.
Impact on stock price depends on use of proceeds.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Alector prices 36.6M share offering at $2.05, about $75 million proceeds

Alector inks Genentech AL050 deal; upfront cash extends runway to 2029

GSK terminates Alector neuroscience collaboration on two antibodies after setbacks

Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce

Alector shares plunge after dementia drug fails to slow disease progression